345 results on '"Wack, Andreas"'
Search Results
2. Contributors
3. Endothelial AHR activity prevents lung barrier disruption in viral infection
4. Repair of airway epithelia requires metabolic rewiring towards fatty acid oxidation
5. The role of recruitment versus training in influenza-induced lasting changes to alveolar macrophage function
6. Host-directed immunotherapy of viral and bacterial infections: past, present and future
7. Interplay between CXCR4 and CCR2 regulates bone marrow exit of dendritic cell progenitors
8. A family of conserved bacterial virulence factors dampens interferon responses by blocking calcium signaling
9. Influenza A induces lactate formation to inhibit type I IFN in primary human airway epithelium
10. The interferon landscape along the respiratory tract impacts the severity of COVID-19
11. Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy
12. Teaching Old Dogs New Tricks? The Plasticity of Lung Alveolar Macrophage Subsets
13. Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option
14. Microbiota-Driven Tonic Interferon Signals in Lung Stromal Cells Protect from Influenza Virus Infection
15. Monocyte and dendritic cell defects in COVID-19
16. Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection
17. Regulation of BCR-mediated Ca2+ mobilization by MIZ1-TMBIM4 safeguards IgG1+ GC B cell–positive selection.
18. Monocytes work harder under pressure
19. Interactions with Multiple Peptide Ligands Determine the Fate of Developing Thymocytes
20. Type I interferons drive MAIT cell functions against bacterial pneumonia
21. Regulation of BCR-mediated Ca2+ mobilization by MIZ1-TIMBIM4 safeguards IgG1+ GC B cell positive selection
22. Chapter 3 - Immunology of COVID-19
23. Never trust a single myeloid marker: Ly6G on repair-promoting lung macrophages.
24. A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
25. Respiratory viruses: New frontiers—a Keystone Symposia report
26. IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
27. Impaired immune response drives age-dependent severity of COVID-19
28. Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model
29. Influenza A Virus Impairs Control of Mycobacterium tuberculosis Coinfection Through a Type I Interferon Receptor—Dependent Pathway
30. TRAIL+ monocytes and monocyte‐related cells cause lung damage and thereby increase susceptibility to influenza–Streptococcus pneumoniae coinfection
31. Guarding the frontiers: the biology of type III interferons
32. SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
33. Anti-type I interferon antibodies as a cause of severe COVID-19
34. Host-directed immunotherapy of viral and bacterial infections: past, present and future
35. Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88
36. Toll-Like Receptor 2 Dependent Immunogenicity of Glycoconjugate Vaccines Containing Chemically Derived Zwitterionic Polysaccharides
37. Contribution of cytokines to pathology and protection in virus infection
38. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
39. Surface molecules on stimulated plasmacytoid dendritic cells are sufficient to cross-activate resting myeloid dendritic cells
40. Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model
41. Type I interferons in infectious disease
42. Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection
43. Broad human and animal coronavirus neutralisation by SARS-CoV-2 S2-targeted vaccination
44. Unique and overlapping roles of type I and type III interferons in influenza pathology and therapy: ID: 151
45. Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation
46. Immunology of TLR-independent vaccine adjuvants
47. Recruitment of dendritic cell progenitors to foci of influenza A virus infection sustains immunity
48. A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza
49. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice
50. Safety of MF59™ adjuvant
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.